CMG three-lens brief
Evidence-based stock research on CMG. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $43.74 — 28% above current (35 analysts). · Debt-to-equity of 179.3 — balance-sheet-heavy.
- Analyst mean target $43.74 — 28% above current (35 analysts).
- Debt-to-equity of 179.3 — balance-sheet-heavy.
CMG closed at $34.21 (+0.91%) as of 2026-04-25. Market cap: $44.56B. P/E (trailing) 30.0. Positives: analyst mean target $43.74 — 28% above current (35 analysts).. Concerns: debt-to-equity of 179.3 — balance-sheet-heavy.. Last quarter: Revenue $2.98B, net income $330.93M, free cash flow $1.01B.
Why three lenses on CMG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CMGacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CMG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CMG brief"></iframe>